INVESTOR PROFILE
Bristol Myers Squibb
Bristol Myers Squibb or BMS is one of the world’s largest biopharmaceutical companies developing medicines in oncology, hematology, immunology and cardiovascular disease. It invests directly and via VC funds, including Life Sciences Partners (LSP) and BioGeneration Ventures, as LP. BMS is headquartered in New York and has 10 offices and facilities within the US and 13 in overseas locations, namely, Puerto Rico, Canada, France, Belgium, the UK, Ireland, Germany, Japan and China.
